Molecular studies in heart hypertrophy during pregnancy.
Stefani
E
E
Division of Molecular Medicine, Departments of Anesthesiology, Physiology, and Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Eghbali
M
M
Minosyan
T
T
Alioua
A
A
Toro
L
L
D000081247:CSK Tyrosine-Protein Kinase; D006332:Cardiomegaly / Q000201:enzymology / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D051242:Caveolin 1; D022461:Caveolins / Q000378:metabolism; D005260:Female; D006801:Humans; D024642:Potassium Channels, Voltage-Gated / Q000096:biosynthesis / Q000235:genetics; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D011505:Protein-Tyrosine Kinases / Q000096:biosynthesis / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D051672:Shal Potassium Channels; D019061:src-Family Kinases
D051242:Caveolin 1; D022461:Caveolins; D024642:Potassium Channels, Voltage-Gated; D012333:RNA, Messenger; D051672:Shal Potassium Channels; D011505:Protein-Tyrosine Kinases; D000081247:CSK Tyrosine-Protein Kinase; D019061:src-Family Kinases; C000631346:CSK protein, human